Cancer Research Career Enhancement and Related Activities Project Summary Both innovation and implementation of cancer solutions requires development of a highly trained cancer- focused workforce. To promote this objective, the PCCR tightly integrates sponsorship of a diverse array of educational and professional development activities within its broad portfolio of research objectives. The institutional home of PCCR, Purdue, presents an outstanding opportunity to further grow this cancer workforce. Purdue is a leading R1 institution with an exceptional diversity of research expertise and a deep commitment to its education mission. Purdue sponsors numerous programs that explicitly promote education and training. It similarly supports many programs that promote professional development at all training levels, from undergraduate to faculty. These programs, however, are typically not framed in a cancer-relevant context. In order to have the greatest impact on the cancer workforce of the future, an overarching goal of the PCCR with regards to education and professional development is to provide a cancer focus to existing Purdue-sponsored activities that would not exist in the absence of the Center and thereby leverage these activities for a cancer- relevant purpose. Similarly, by promoting cancer-relevant aspects of these educational and professional development programs, the PCCR promotes opportunities available in the cancer research field that many of the outstanding faculty, students and staff at Purdue would otherwise be unfamiliar with and, thereby, recruits these individuals to the fight against cancer. In short, the PCCR both promotes its own programs and coordinates with various Purdue academic and administrative units to explicitly leverage Purdue's abundant institutional resources in order to have the largest impact on cancer-focused education and professional development. Initiatives addressing education and professional development are grouped into four themes: 1) Building a cancer-focused community of practice to facilitate interdisciplinary training that exploits the diversity of research expertise at Purdue; 2) Promoting faculty development and helping to recruit top-tier basic scientists into cancer- related research; 3) Promoting graduate student education and training by designing PCCR-sponsored activities such that graduate student education and professional development are built into the experience; and 4) Promoting undergraduate opportunities and thereby shape career paths and intentions of Purdue's extensive undergraduate population. Specific examples of PCCR activities/programs include: 1) a bioinformatics training program that targets graduate students; 2) a Continuing Umbrella of Research Experience (CURE)-funded summer research program for graduate students who are underrepresented minorities; 3) a program for faculty and postdocs in the physical sciences that promotes cancer-related research and embeds them in a clinical setting; 4) training of graduate students to use PCCR-sponsored shared resources; and 5) interdisciplinary training for graduate students and faculty via a cancer journal club. By intentionally embracing training within its discovery mission, the PCCR is fostering both the innovations of today and the innovators of tomorrow.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023168-40
Application #
10024907
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-08-01
Budget End
2021-06-30
Support Year
40
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Purdue University
Department
Type
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Lee, Hyeon Jeong; Li, Jie; Vickman, Renee E et al. (2018) Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/?-catenin Pathway. Mol Cancer Res 16:974-985
Bhandari, Pushpak; Novikova, Gloriia; Goergen, Craig J et al. (2018) Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy. Sci Rep 8:3112
Dhawan, Deepika; Hahn, Noah M; Ramos-Vara, José A et al. (2018) Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer. PLoS Genet 14:e1007571
Shinde, Aparna; Libring, Sarah; Alpsoy, Aktan et al. (2018) Autocrine Fibronectin Inhibits Breast Cancer Metastasis. Mol Cancer Res 16:1579-1589
Ghosh, Arun K; Ghosh, Koena; Brindisi, Margherita et al. (2018) Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand. Bioorg Med Chem Lett 28:2605-2610
Thompson, Taylor J; Han, Bumsoo (2018) Analysis of adhesion kinetics of cancer cells on inflamed endothelium using a microfluidic platform. Biomicrofluidics 12:042215
Alpsoy, Aktan; Dykhuizen, Emily C (2018) Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes. J Biol Chem 293:3892-3903
Kumari, Rashmi; Silic, Martin R; Jones-Hall, Yava L et al. (2018) Identification of RECK as an evolutionarily conserved tumor suppressor gene for zebrafish malignant peripheral nerve sheath tumors. Oncotarget 9:23494-23504
Larocque, Elizabeth A; Naganna, N; Opoku-Temeng, Clement et al. (2018) Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase. ChemMedChem 13:1172-1180
Poh, Scott; Chelvam, Venkatesh; Ayala-López, Wilfredo et al. (2018) Selective liposome targeting of folate receptor positive immune cells in inflammatory diseases. Nanomedicine 14:1033-1043

Showing the most recent 10 out of 436 publications